Joonas H. Kauppila

Dr. Joonas H. Kauppila


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2013 in Head & Neck
Verified
Journal Article
Open access
PDF file
AAAlhadi Almangush
Alhadi Almangush
IBIbrahim O. Bello
Ibrahim O. Bello
HKHarri Keski–Säntti
Harri Keski–Säntti
LMLaura K. Mäkinen
Laura K. Mäkinen
JKJoonas H. Kauppila
Joonas H. Kauppila
TSTuula Salo
Tuula Salo
Background Oral (mobile) tongue squamous cell carcinoma (SCC) is characterized by a highly variable prognosis in early‐stage disease (T1/T2 N0M0). The ability to classify early oral tongue SCCs into low‐risk and high‐risk categories would represent a major advancement in their management. Methods Depth of invasion, tumor budding, histologic risk‐assessment score (HRS), and cancer‐associated fibroblast (CAF) density were studied in 233 cases of T1/T2 N0M0 oral tongue SCC managed in 5 university hospitals in Finland. Results Tumor budding (≥5 clusters at the invasive front of the tumor) and depth of invasion (≥4 mm) were associated with poor prognosis in patients with early oral tongue SCC (hazard ratio [HR], 2.04; 95% confidence interval [CI], 1.17–3.55; HR, 2.55; 95% CI, 1.25–5.20, respectively) after multivariate analysis. The HRS and CAF density did not predict survival. However, high‐risk worst pattern of invasion (WPOI), a component of HRS, was also an independent prognostic factor (HR, 4.47; 95% CI, 1.59–12.51). Conclusion Analyzing the depth of invasion, tumor budding, and/or WPOI in prognostication and treatment planning of T1/T2 N0M0 oral tongue SCC is recommended. © 2013 The Authors. Head Neck, 2013

1 December 2019 in Annals of Surgery
Verified
Journal Article
Closed access
EGEivind Gottlieb-Vedi
Eivind Gottlieb-Vedi
JKJoonas H. Kauppila
Joonas H. Kauppila
GMGeorge Malietzis
George Malietzis
MNMagnus Nilsson
Magnus Nilsson
SMSheraz R. Markar
Sheraz R. Markar
JLJesper Lagergren
Jesper Lagergren
Objective: Evaluate the existing literature comparing long-term survival after minimally invasive esophagectomy (MIE) and open esophagectomy (OE), and conduct a meta-analysis based on relevant studies. Background: It is unknown whether the choice between MIE and OE influences the long-term survival in esophageal cancer. Methods: A systematic electronic search for articles was performed in Medline, Embase, Web of Science, and Cochrane Library for studies comparing long-term survival after MIE and OE. Additionally, an extensive hand-search was conducted. The I 2 test and χ2 test were used to test for statistical heterogeneity. Publication bias and small-study effects were assessed using Egger test. A random-effects meta-analysis was performed for all-cause 5-year (main outcome) and 3-year mortality, and disease-specific 5-year and 3-year mortality. Meta-regression was performed for the 5-year mortality outcomes with adjustment for the covariates age, physical status, tumor stage, and neoadjuvant or adjuvant therapy. The results were presented as hazard ratios (HRs) with 95% confidence intervals (CIs). Results: The review identified 55 relevant studies. Among all 14,592 patients, 7358 (50.4%) underwent MIE and 7234 (49.6%) underwent OE. The statistical heterogeneity was limited [I 2 = 12%, 95% confidence interval (CI) 0%–41%, and χ2 = 0.26] and the funnel plot was symmetrical both according to visual and statistical testing (Egger test = 0.32). Pooled analysis revealed 18% lower 5-year all-cause mortality after MIE compared with OE (HR 0.82, 95% CI 0.76–0.88). The meta-regression indicated no confounding. Conclusions: The long-term survival after MIE compares well with OE and may even be better. Thus, MIE can be recommended as a standard surgical approach for esophageal cancer.

3 April 2015 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
AAAlhadi Almangush
Alhadi Almangush
IBIbrahim O. Bello
Ibrahim O. Bello
RCRicardo D. Coletta
Ricardo D. Coletta
AMAntti A. Mäkitie
Antti A. Mäkitie
LMLaura K. Mäkinen
Laura K. Mäkinen
TSTuula Salo
Tuula Salo

30 July 2018 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
NKNiko Kemi
Niko Kemi
MEMaarit Eskuri
Maarit Eskuri
AHAnni Herva
Anni Herva
JLJoni Leppänen
Joni Leppänen
HHHeikki Huhta
Heikki Huhta
JKJoonas H. Kauppila
Joonas H. Kauppila
Background Tumour microenvironment, including tumour–stroma ratio (TSR), might help identifying high-risk cancer patients. However, the significance of TSR in gastric cancer is unclear, especially in the intestinal and diffuse subtypes. The aim of this study was to investigate the tumour–stroma ratio in gastric adenocarcinoma, and its intestinal and diffuse histological subtypes, in relation to prognosis. Methods Five hundred and eighty-three gastric adenocarcinoma patients who underwent surgery in Oulu University hospital during years 1983–2016 were included in this retrospective cohort study. TSR was analysed from the slides that were originally used for diagnostic purposes. Patients were divided into stroma-poor (≤50% stroma) and stroma-rich (>50% stroma) groups and TSR was analysed in relation to 5-year mortality and overall mortality. Results Patients with stroma-rich tumours had worse 5-year prognosis (HR 1.80, 95% CI 1.41–2.28) compared to stroma-poor tumours. Stratified analysis showed that stroma-rich tumours had worse 5-year prognosis in both intestinal (HR 1.68, 95% CI 1.24–2.27) and diffuse histological types (HR 2.09, 95% CI 1.35–3.23) compared to stroma-poor tumours, respectively. Conclusions High proportion of stroma is an independent prognostic factor in both intestinal and diffuse histological subtypes of gastric adenocarcinoma.

9 July 2018 in Annals of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JAJohannes Asplund
Johannes Asplund
JKJoonas H. Kauppila
Joonas H. Kauppila
FMFredrik Mattsson
Fredrik Mattsson
JLJesper Lagergren
Jesper Lagergren
Background Gastric adenocarcinoma is the second most common cancer-related death globally. Assessing survival trends can help evaluate changes in detection and treatment. We aimed to determine recent...

1 February 2015 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
AAAlhadi Almangush
Alhadi Almangush
RCR.D. Coletta
R.D. Coletta
IBI.O. Bello
I.O. Bello
CBC. Bitu
C. Bitu
HKH. Keski-Säntti
H. Keski-Säntti
TSTuula Salo
Tuula Salo